• SPX
  • $5,758.49
  • 0.8 %
  • $45.80
  • DJI
  • $42,150.94
  • 0.85 %
  • $356.34
  • N225
  • $38,474.90
  • 1.11 %
  • $421.23
  • FTSE
  • $8,160.99
  • -0.28 %
  • -$23.25
  • IXIC
  • $18,353.68
  • 0.96 %
  • $173.70
Silverback Therapeutics, Inc. (SBTX) Earning

Silverback Therapeutics, Inc. (SBTX) Earning

NASDAQ Currency in USD Disclaimer

Stock Price
Day's range
$5.82
Day's range
$6.15

Silverback Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/09/2023 Q3 2023 -$0.00 $0
08/10/2023 Q2 2023 -$0.00 $0
05/15/2023 Q1 2023 -$0.00 $0
03/23/2023 Q4 2022 $0.72 $0
11/02/2022 Q3 2022 -$0.35 -$0.53 -0.18 $0
08/11/2022 Q2 2022 -$0.48 -$0.56 -0.08 $0
05/12/2022 Q1 2022 -$0.54 -$0.70 -0.16 $0
03/31/2022 Q4 2021 -$0.70 -$0.67 0.03 $0
11/10/2021 Q3 2021 -$0.67 -$0.65 0.02 $0
08/12/2021 Q2 2021 -$0.53 -$0.70 -0.17 $0
05/13/2021 Q1 2021 -$0.35 -$0.54 -0.19 $0
03/29/2021 Q4 2020 -$1.37 $-3,535,000
09/29/2020 Q3 2020 -$0.28 $0
06/29/2020 Q2 2020 -$0.70 $0
03/30/2020 Q1 2020 -$0.57 $0
12/30/2019 Q4 2019 -$0.73 $0
 

Silverback Therapeutics, Inc. Earnings: Frequently Asked Questions

  • Did Silverback Therapeutics, Inc. beat their earnings estimates last quarter?

    In the previous quarter, Silverback Therapeutics, Inc. (:SBTX) reported $-0.00012 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.34 by $0.33988.

  • How can I listen to Silverback Therapeutics, Inc.'s earnings conference call?

    The conference call for Silverback Therapeutics, Inc.'s latest earnings report can be listened to online.

  • How can I read Silverback Therapeutics, Inc.'s conference call transcript?

    The conference call transcript for Silverback Therapeutics, Inc.'s latest earnings report can be read online.

  • How much profit does Silverback Therapeutics, Inc. generate each year?

    Silverback Therapeutics, Inc. (:SBTX) has a recorded net income of $0. Silverback Therapeutics, Inc. has generated $-0.85 earnings per share over the last four quarters.

  • What is Silverback Therapeutics, Inc.'s price-to-earnings ratio?

    Silverback Therapeutics, Inc. (:SBTX) has a price-to-earnings ratio of -38186.41 and price/earnings-to-growth ratio is -136.89.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.